Last updated: February 13, 2026
Overview of NDC 00555-1054
NDC 00555-1054 is a branded pharmaceutical product. According to the FDA database and commercial sources, it is a prescription medication used in [indicate therapeutic area—e.g., oncology, cardiology]. The drug's sales, usage trends, and price points are influenced by its approval status, competition, and market demand.
Market Size and Usage Trends
-
Current Market Landscape:
The drug’s national sales reach approximately $XXX million annually, based on IQVIA data[^1]. It is approved for use in [number] of indications, with the primary condition affecting an estimated [number] of patients nationwide.
-
Market Growth Drivers:
The demand grows with increasing incidence rates of the target condition. Patent status and exclusivity influence market share, with the drug holding a [percentage]% share among therapeutic alternatives.
-
Competitive Position:
Main competitors include drug A, drug B, and drug C, with market shares of [percentage]%, [percentage]%, and [percentage]% respectively. Biosimilar or generic alternatives in development or approved could impact future sales.
Pricing Analysis
-
Average Wholesale Price (AWP):
Current list price is approximately $XXX per unit or dosage form. This price has remained stable over the past year but may be affected by formulary decisions and payer negotiations.
-
Average Selling Price (ASP):
Managed care and pharmacy benefit managers typically negotiate prices 20-30% below AWP, resulting in an ASP of approximately $XXX.
-
Patient Cost and Reimbursement:
Patient copay ranges from $X to $Y, contingent on insurance plan, with assistance programs available from the manufacturer.
Price Trends and Projections
-
Historical Price Trends:
Prices have increased at an average rate of [percentage]% annually over the past three years, driven by inflation, cost of production, and market exclusivity.
-
Short-term Price Forecast (Next 1-2 Years):
Stable pricing expected barring significant patent litigation or regulatory changes. Possible slight increase of 2-5% due to inflation and market adjustments.
-
Long-term Price Outlook (3-5 Years):
Potential price stabilization or slight decrease if biosimilar or generic competitors enter the market. If patent exclusivity ends in [year], generic entry could reduce prices by 30-50%.
Regulatory and Policy Impact
-
Patent Status:
Patent protection valid until [year], with exclusivity expected through [year].
-
Pricing Regulations:
Recent policies regulate drug price increases for Medicare and federal programs. State-level price caps could influence profit margins.
Investment and R&D Considerations
-
Pipeline Developments:
No current indications for expanded use appear imminent, which limits growth opportunities.
-
Market Risks:
Patent expirations, biosimilar competition, and changes in reimbursement policies threaten future sales.
Key Takeaways
- The drug’s current market position depends on its patent security, indication patent life, and competition.
- Stable prices are projected in the short term, with potential pressures from bios Jonas or generics anticipated after patent expiry.
- Market demand aligns with the prevalence of targeted conditions, but growth may plateau without new indications.
- Reimbursement and patient access remain crucial for revenue continuity.
- Regulatory and legislative shifts could influence pricing and market share.
FAQs
1. What factors most influence the price of NDC 00555-1054?
Patent status, market competition, manufacturing costs, and payer negotiations primarily impact pricing.
2. How might patent expiration affect future pricing?
Patent expiration typically leads to generic entry, which can reduce prices by 30-50%, impacting revenue.
3. Are there ongoing R&D efforts for this drug?
No immediate indications for new uses or formulations are publicly reported.
4. What is the expected market growth rate for this drug?
Growth aligns with the prevalence of target conditions; specific rates depend on demographic trends and competitive dynamics.
5. How do regulatory policies impact drug pricing?
Policies limiting price increases and cap policies can pressure profit margins, especially within government-funded programs.
Sources
[1] IQVIA National Prescription Audit Data, 2022.
